USE OF CURCUMIN AND ITS DERIVATES IN PREVENTION AND TREATMENT OF HYPEROXIA-DERIVED RESPIRATORY DISEASES IN PRETERM INFANTS: A SUMMARY REVIEW
Abstract
Keywords
Full Text:
PDFReferences
Aggarwal, B., Kumar, A., Bharti, A. (2003). “Anticancer potential of curcumin: preclinical and clinical studies”. Anticancer Res. 23(1A):363-398.
Ammon, W. M. (1991). “Pharmacology of Curcuma longa”. Planta Med. 57(1):1 7.
Barazzone, C., White C. (2000). “Mechanisms of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins”. Am J Respir Cell Mol Biol. 22(5):517-9.
Biswas, S. K. (2016). “Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?” Oxid. Med. Cell. Longev. 2016(5698931):1 9.
Bonikos, D., Bensch, K., Northway, W. J. (1976). “Oxygen toxicity in the newborn. The effect of chronic continuous 100 percent oxygen exposure on the lungs of newborn mice”. Am J Pathol. 85(3):623-50.
Cosgrave, E., Scott, C., Goble. R. (2008). “Ocular findings in low birthweight and prematurebabies in the first year: Do we need to screen?” Eur J Ophthalmol. 18(1):104-111.
Frank, L., Bucher, J., Roberts, R. (1978).”Oxygen toxicity in neonatal and adult animals of various species”. J Appl Physiol. 45(5):699-704.
Guyton, A. C., Hall, J. E. (2003). Medicinska fiziologija, deseto izdanje. Medicinska naklada. Zagreb.
Hoffman, M., Stevens, Ј. (1980). “Adaptation to hyperoxia in the neonatal rat: kinetic parameters of the oxygen-mediated induction of lung superoxide dismutases, catalase and glutathione peroxidase”. Toxicology. 16(3):215-225.
Jensen, E. Schmidt, B. (2014). “Epidemiology of bronchopulmonary dysplasia”. Birth Defects Res A Clin Mol Teratol. 100(3):145-157.
Küpper, F.C. et. al. (2013). “In vivo speciation studies and antioxidant properties of bromine in Laminaria digitata reinforce the significance of iodine accumulation for kelps”. J. Exp. Bot. 64(10):2653-2664.
Li, C. et al. (2018). “Novel Curcumin C66 That Protects Diabetes-Induced Aortic Damage Was Associated with Suppressing JNK2 and Upregulating Nrf2 Expression and Function”. Oxidative Medicine and Cellular Longevity. 2018(5783239):1-12.
Lin, Y. G. et al. (2007). “Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway”. Clin. Cancer Res. 13(11):3423 3430.
Liu, L., Oza, S., Hogan, D., Chu, Y., Perin, J., Zhu, J. et al. (2016). “Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals”. Lancet. 388(10063):3027-35.
Liu, L., Shang, Y., Li, M., Han, X., Wang, J., Wang, Juan. (2015). “Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor-E2-related factor 2/haem oxygenase (HO)-1 signalling pathway”. Clinical and Experimental Pharmacology and Physiology. 42(5):520-529.
Marchiani, A., Rozzo, C., Fadda, A., Delogu, G., Ruzza, P. (2014). “Curcumin and curcumin-like molecules: From spice to drugs”. Curr. Med. Chem. 21(2):204-22.
March of Dimes, PMNCH, Save the Children, WHO. (2012). Born Too Soon: The Global Action Report on Preterm Birth. Eds CP Howson, MV Kinney, JE Lawn. World Health Organization. Geneva.
Menon, V. P., Sudheer., A. R. (2007). “Antioxidant and anti-inflammatory properties of curcumin”. Adv. Exp. Med. Biol. 95(2007):105-125.
Ogawa, Y., Tasaka, S., Yamada, W., Saito, F., Hasegawa, N., Miyasho, T., Ishizaka, A. (2007). “Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice”. Inflamm. Res. 56(8):334-338.
O’Reilly, M., Thébaud, B. (2014). “Animal models of bronchopulmonary dysplasia. The term rat models”. Am J Physiol Lung Cell Mol Physiol. 307(12):948-958.
Pan, Y. et al. (2012). “Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats”. Br. J. Pharmacol. 166(3):1169-1182.
Pan, Y., Huang,Y., Wang, Z., et al. (2014). “Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy”. J Cell Mol Med. 18(2):231-24.
Panahi, Y., Hosseini, Y. M. S., Khalili, N., Naimi, E., Simental-Mendia, L. E., Majeed, M., Sahebkar, A. (2016). “Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial”. Biomed. Pharmacother. 82(2016):578-582.
Randell, S., Mercer, R., Young, S. (1990). “Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats”. Am J Pathol. 136(6):1259-1266.
Ren, J., Sowers. J. R. (2014). “Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy”. Diabetes. 63(10):3166-3168.
Sahebkar, A., Serbanc, M. C., Ursoniuc, S., Banach. M. (2015). “Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials”. J. Funct. Foods. 18(2015):898-909.
Shakeri, F, Soukhtanloo, M, Boskabady, М. (2017). “The effect of hydro-ethanolic extract of Curcuma longa rhizome and curcumin on total and differential WBC and serum oxidant, antioxidant biomarkers in rat model of asthma.” Iran J Basic Med Sci. 20(2):155-165.
Shoba, G. et al. (1998). “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers”. Planta Med. 64(4):353-356.
Smith, L., McKay, K., van Asperen, P., Selvadurai , H., Fitzgerald, D. (2010). Normal development of the lung and premature birth. Paediatr Respir Rev. 11(3):135-142.
Subhashini, P. S. et al. (2016). “Intranasal curcumin ameliorates airway inflammation and obstruction by regulating MAPKinase activation (p38, Erk and JNK) and prostaglandin D2 release in murine model of asthma”. International Immunopharmacology. 31(2016):200-206.
Vento, M., Moro, M., Escrig, R. et al. (2009). “Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease”. Pediatrics. 124(3):e439-49.
Warner, B., Stuart, L., Papes, R., Wispe, J. (1998). “Functional and pathological effects of prolonged hyperoxia in neonatal mice”. Am J Physiol. 275(1):110-7.
Wilson, W., Mullen, M, Olley, P., Rabinovitch, M. (1985). “Hyperoxia induced pulmonary vascular and lung abnormalities in young rats and potential for recovery”. Pediatr Res. 19:1059-1067.
Yee, M., White, R., Awad, H., Bates, W., McGrath-Morrow, S., O’Reilly, M. (2011). “Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice”. Am J Pathol. 178(6):2601-10.
Refbacks
- There are currently no refbacks.
New knowledge Journal of science is financed by the National Science Fund of the Republic of Bulgaria - contract № КП-06-НП1/5 of 17.12.2019 in the competition of Bulgarian scientific periodicals – 2019
New knowledge Journal of science is financed by the National Science Fund of the Republic of Bulgaria – contract № ДНП 05/52 от 22.12.2016 in the competition of Bulgarian scientific periodicals – 2016
The contents of this publication do not necessarily reflect the position or opinion of the National Science Fund of the Republic of Bulgaria. The opinions expressed are those of the author(s) only and should not be considered as representative of the National Science Fund’s official position.